These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1923603)
41. Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice. Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1037-48. PubMed ID: 14682385 [TBL] [Abstract][Full Text] [Related]
42. [Preiliminary studies on the efficacy and mechanism of interleukin-3 in the treatment of myelosuppression in mice]. Chen J; Hu W; Zhao S; Zhang Y Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 May; 13(2):134-7. PubMed ID: 10074234 [TBL] [Abstract][Full Text] [Related]
43. [Significance of sympathetic-adrenal structures in hematopoiesis regulation in cytostatic myelodepression]. Khlusov IA; Dygaĭ AM; Aksinenko SG; Gol'dberg ED Biull Eksp Biol Med; 1993 Apr; 115(4):372-5. PubMed ID: 7914102 [TBL] [Abstract][Full Text] [Related]
44. Restoration of hematopoietic activity by lipid A analogue GLA-60 in cyclophosphamide-treated immunosuppressed mice. Ikeda S; Kaneko M; Nishiya S; Nishimura C J Clin Lab Immunol; 1990 Aug; 32(4):189-93. PubMed ID: 1966937 [TBL] [Abstract][Full Text] [Related]
45. Lithium and hematopoietic toxicity. I. Recovery in vivo of murine hematopoietic stem cells (CFU-S and CFU-Mix) after single-dose administration of cyclophosphamide. Gallicchio VS Exp Hematol; 1986 Jun; 14(5):395-400. PubMed ID: 3709709 [TBL] [Abstract][Full Text] [Related]
46. Stromal cells in long-term cultures of liver, spleen, and bone marrow at different developmental ages have different capacities to maintain GM-CFC proliferation. Van Den Heuvel R; Schoeters G; Leppens H; Vanderborght O Exp Hematol; 1991 Feb; 19(2):115-21. PubMed ID: 1991493 [TBL] [Abstract][Full Text] [Related]
47. Potentiation of myeloid colony-formation in bone marrow of intact and neonatally thymectomized mice by the thymic hormone THF-gamma 2. Pecht M; Lourie S; Burstein Y; Zipori D; Trainin N Exp Hematol; 1993 Feb; 21(2):277-82. PubMed ID: 8425564 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of normal granulopoiesis by cytostatic agents. Szmigielski S; Jeljaszewicz J Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(5):678-85. PubMed ID: 64408 [TBL] [Abstract][Full Text] [Related]
49. [Mechanisms of hemopoiesis cytostatic damage and regeneration]. Gol'dberg ED; Dygaĭ AM; Zdanov VV Vestn Ross Akad Med Nauk; 1998; (10):6-10. PubMed ID: 9846103 [TBL] [Abstract][Full Text] [Related]
50. [The role of the hemopoiesis-inducing microenvironment in the mechanisms of the regeneration of hemopoiesis after cytostatic exposure]. Dygaĭ AM; Zhadanov VV; Bogdashin IV; Gol'dberg VE Nauchnye Doki Vyss Shkoly Biol Nauki; 1992; (9):109-16. PubMed ID: 1302526 [TBL] [Abstract][Full Text] [Related]
51. [The role of glycosaminoglycans in the local regulation of hemopoiesis in exposure of the body to extreme factors]. Iastrebov AP; Iushkov BG; Savel'ev LI Patol Fiziol Eksp Ter; 1991; (3):10-2. PubMed ID: 1923602 [TBL] [Abstract][Full Text] [Related]
52. Effect of thymus-dependent antigen on recovery of hemo- and lymphopoiesis impaired by antineoplastic drugs. Masnaya NV; Ratner GM Bull Exp Biol Med; 2000 Jun; 129(6):587-91. PubMed ID: 11022258 [TBL] [Abstract][Full Text] [Related]
53. Effect of cytostatics on bone marrow stem cells. Goldberg ED; Dygai AM; Zhdanov VV Bull Exp Biol Med; 2005 Jan; 139(1):121-5. PubMed ID: 16142293 [TBL] [Abstract][Full Text] [Related]
54. [Effect of talliblastine on several hematologic indices]. Astardzhieva Z; Stoichkov I; Mircheva I Eksp Med Morfol; 1977; 16(3):151-5. PubMed ID: 144597 [TBL] [Abstract][Full Text] [Related]
55. Multisystem stem cell failure after apparent recovery from alkylating agents. Botnick LE; Hannon EC; Hellman S Cancer Res; 1978 Jul; 38(7):1942-7. PubMed ID: 657132 [No Abstract] [Full Text] [Related]
56. [Action of carminomycin on the kinetics of cell proliferation and some problems of its combined use with other cytostatic agents]. Egorov LV; Khanykova OK; Kuznetsova TV; Gerasimova NA; Kozinets GI Antibiotiki; 1977 Jul; 22(7):639-43. PubMed ID: 883808 [TBL] [Abstract][Full Text] [Related]
57. Role of cell-cell interactions in the regulation of hemopoiesis during cytostatic-induced myelosuppression. Zhdanov VV; Udut EV; Gur'yantseva LA; Danilets MG; Dygai AM; Gol'dberg ED Bull Exp Biol Med; 2001 Aug; 132(2):744-7. PubMed ID: 11713554 [TBL] [Abstract][Full Text] [Related]
58. [Experimental study of late effects of the damaging action of doxorubicin on the lymphoid tissue]. Zapuskalova OB; Novitskiĭ VV; Go'ldberg ED Antibiot Khimioter; 1989 Nov; 34(11):855-9. PubMed ID: 2633704 [TBL] [Abstract][Full Text] [Related]
59. [Regulating effect of the hematopoiesis-inducing microenvironment on hematopoietic processes as affected by cytostatic drugs]. Dygaĭ AM; Zhdanov VV; Khlusov IA; Liubavina PA; Gol'dberg ED Gematol Transfuziol; 1995; 40(5):11-5. PubMed ID: 8566652 [TBL] [Abstract][Full Text] [Related]
60. Cell-cycle specificity and therapeutic effectiveness of cytostatic agents. Van Putten LM; Lelieveld P; Kram-Idsenga LK Cancer Chemother Rep; 1972 Dec; 56(6):691-700. PubMed ID: 4512950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]